Biodexa Pharmaceuticals American Depositary Shs (BDRX) vs Capstone (CAPS)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
Capstone is the larger company by market cap ($1.3 million vs $982,950), about 1.4 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | BDRX | CAPS |
|---|---|---|
| Share price | $1.88 | $1.44 |
| Market cap | $982.95K | $1.35M |
| 1-day change | -3.85% | -9.15% |
| P/E ratio (TTM) | 0.00 | — |
| EPS (TTM) | $509.89 | $-89.68 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | — | $46.88M |
| Revenue growth (YoY) | — | +4.47% |
| Net income (latest FY) | — | $-21.23M |
| Gross margin | — | 23.02% |
| Operating margin | — | -23.43% |
| Net margin | — | -45.28% |
| 52-week high | $357.60 | $28.50 |
| 52-week low | $1.85 | $1.42 |
| Distance from 52-week high | -99.48% | -94.95% |
| Analyst consensus | none | none |
| Avg. price target upside | +375.20% | +108.33% |
| Average volume | 618.91K | 153.70K |
| Shares outstanding | 524.24K | 935.38K |
| Employees | 11 | 93 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Biodexa Pharmaceuticals American Depositary Shs
BDRX stock →Biodexa Pharmaceuticals Plc, a clinical stage biopharmaceutical company, focuses on developing a pipeline of products for the treatment of familial adenomatous polyposis, non-muscle invasive bladder cancer, and Type 1 diabetes and rare/orphan brain cancer. Its lead product candidate, Tolimidone, is a selective activator of the lyn kinase enzyme, currently under Phase II studies for the treatment of Type 1 diabetes.
Health Care · Biotechnology: Pharmaceutical Preparations · 11 employees
About Capstone
CAPS stock →Capstone Holding Corp., through its subsidiaries, engages in the distribution and installation of building products in the United States and Canada. It operates in two segments, TotalStone and Carolina Stone.
Health Care · Biotechnology: Pharmaceutical Preparations · 93 employees
BDRX vs CAPS FAQ
Which is bigger, Biodexa Pharmaceuticals American Depositary Shs or Capstone?
Capstone (CAPS) is larger, with a market capitalization of $1.35M compared with $982.95K for Biodexa Pharmaceuticals American Depositary Shs (BDRX).
Are Biodexa Pharmaceuticals American Depositary Shs and Capstone in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.